x

Búsqueda de un ensayo clínico

* (*) Campo obligatorio

245 Resultado(s)

Ordenados por

Ensayo clínico en reclutamiento = Ensayo clínico en reclutamiento
; Ensayos clínico en curso = Ensayos clínico en curso 
; Financiado por un miembro del IRDiRC =

Ensayo(s) clínico(s) nacional(es)

ALEMANIA

Baden-Württemberg
ULM

Ensayo clínico en reclutamiento
Ensayos clínico en curso 
EMAA: Efficacy and Safety of Eltrombopag in Patients with Acquired Moderate Aplastic Anemia who are treated with Ciclosporin A (Phase II/III) - DE
DRK Baden-Württemberg/ Hessen
Institut für Klinische Transfusionsmedizin und Immungenetik Ulm

ALEMANIA

Sachsen
DRESDEN

Ensayos clínico en curso 
A phase III, multicenter, randomised, double-blind, placebo-controlled study of Darbepoetin Alfa for the treatment of anaemic subjects with low or intermediate-1 risk Myelodysplastic Syndrome - DE
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Medizinische Klinik und Poliklinik I - Fachbereich Hämatologie und Blutstammzelltransplantation

ALEMANIA

Baden-Württemberg
HEIDELBERG

Ensayos clínico en curso 
MPN-SG 01-09 (MPN Pomalidomide): Multicenter Phase II Study with Pomalidomide in patients with Myeloproliferative Neoplasms in fibrotic Stage
Nationales Centrum für Tumorerkrankungen (NCT)
Nationales Centrum für Tumorerkrankungen (CCC) Heidelberg

ALEMANIA

Hamburg
HAMBURG

Ensayo clínico en reclutamiento
Ensayos clínico en curso 
Ruxolitinib versus allogeneic stem cell transplantation for patients with myelofibrosis according to donor availability: A prospective phase II trial (MMM 02 study) - DE
UKE - Universitätsklinikum Hamburg-Eppendorf
Interdisziplinäre Klinik und Poliklinik für Stammzelltransplantation

ALEMANIA

Nordrhein-Westfalen
AACHEN

ALEMANIA

Nordrhein-Westfalen
MINDEN

Ensayos clínico en curso 
JHTB(a): A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms - DE
Johannes Wesling Klinikum Minden
Klinik für Hämatologie, Onkologie und Palliativmedizin

AUSTRIA

WIEN
WIEN

Ensayos clínico en curso 
A Phase 2 Study of LY2784544 in Patients with Myeloproliferative Neoplasms - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

ESPAÑA

Madrid
ADDRESS: NOT PROVIDED - ES

ESTADOS UNIDOS

Ohio
CINCINNATI

Ensayo clínico en reclutamiento
Ensayos clínico en curso 
Financiado por un miembro del IRDiRCQuercetin in Children With Fanconi Anemia; a Pilot Study (Phase 1/2) - US
Cincinnati Children's Hospital Medical Center
Department of Pediatry

FRANCIA

BRETAGNE
BREST

Thalidomide treatment for agnogenic myeloid metaplasia (Phase II) - Terminated -
CHU de Brest - Hôpital de la Cavale Blanche
Laboratoire d'hématologie

FRANCIA

ILE-DE-FRANCE
PARIS

VPACS : Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease With Vaso-occlusive Crisis and Morphinic Treatment
Hôpital Necker-Enfants Malades
Service de Réanimation et unités de soins continus médico-chirurgicale pédiatriques

FRANCIA

OUTRE-MER
FORT DE FRANCE

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH) (Phase III)
CHU de Martinique - Hôpital P. Zobda-Quitman
Cardiologie Pédiatrique et Congénitale

PAISES BAJOS (LOS)

Gelderland
NIJMEGEN

PAISES BAJOS (LOS)

Noord-Holland
AMSTERDAM

PAISES BAJOS (LOS)

Noord-Holland
AMSTERDAM

Ensayos clínico en curso 
Microvascular Damage in Sickle Cell Disease
Amsterdam UMC, locatie AMC
Afdeling Hematologie

REINO UNIDO (EL)

Greater London
LONDON

REINO UNIDO (EL)

Greater Manchester
ADDRESS: NOT PROVIDED - UK

REINO UNIDO (EL)

Greater Manchester
ADDRESS: NOT PROVIDED - UK

REINO UNIDO (EL)

West Midlands
BIRMINGHAM

ALEMANIA

Baden-Württemberg
HEIDELBERG

An open-label, multicentre controlled clinical trial of Eculizumab in adult patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - DE
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion Pädiatrische Nephrologie

ALEMANIA

Baden-Württemberg
HEIDELBERG

An open-label, multicentre controlled clinical trial of Eculizumab in adult patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - DE
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion Pädiatrische Nephrologie

ALEMANIA

Baden-Württemberg
HEIDELBERG

An open-label, multicentre clinical trial of Eculizumab in pediatric patients with Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - DE- Completed
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion Pädiatrische Nephrologie

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

FRANCIA

NOUVELLE AQUITAINE
PESSAC

ANEMIL : Phase I/II Clinical Trial Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
CHU de Bordeaux-GH Sud - Hôpital Haut-Lévêque
Service de médecine interne et maladies infectieuses (Sud)

ITALIA

EMILIA ROMAGNA
FERRARA

Ensayos clínico en curso 
An Open-Label Extension Study to Evaluate the Long-Term Effects of ACE-536 in Patients With beta-Thalassemia Previously Enrolled in Study A536-04
A.O.U. di Ferrara - Nuovo Ospedale S.Anna - Sede di Cona
Day Hospital della Talassemia e delle Emoglobinopatie

ITALIA

LAZIO
ROMA

Phase 2, Double-Blind, Placebo Controlled Clinical Trial of EPI-743 in Subjects With Cobalamin C Defect
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO
U.O.C. di Patologia Metabolica

ITALIA

LOMBARDIA
MILANO

Ensayo clínico en reclutamiento
Ensayos clínico en curso 
An open-label, multi-center clinical trial of eculizumab in pediatric patients with atypical hemolytic-uremic syndrome (aHUS) (Phase II) - IT
IRCCS Ca' Granda - Ospedale Maggiore Policlinico - Clinica Pediatrica De Marchi
Centro per la Cura e lo Studio della Sindrome Emolitico Uremica (Center for HUS Control)

ITALIA

LOMBARDIA
PAVIA

Eltrombopag per le trombocitopenie ereditarie
Fondazione IRCCS Policlinico San Matteo
Clinica Medica III

PAISES BAJOS (LOS)

Gelderland
NIJMEGEN

REINO UNIDO (EL)

Greater London
LONDON

Ensayos clínico en curso 
An open-label, multi-center clinical trial of eculizumab in pediatric patients with atypical hemolytic-uremic syndrome (aHUS) (Phase II) - UK
University College London Hospitals, NHS Foundation Trust
Renal Office - Consultant Paediatric Nephrologist

REINO UNIDO (EL)

Tyne & Wear
NEWCASTLE UPON TYNE

An open-label, multi-center controlled clinical trial of eculizumab in adult patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

REINO UNIDO (EL)

Tyne & Wear
NEWCASTLE UPON TYNE

An open-label, multi-center controlled clinical trial of eculizumab in adolescent patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

REINO UNIDO (EL)

Tyne & Wear
NEWCASTLE UPON TYNE

An open-label, multi-center controlled clinical trial of eculizumab in adult patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

REINO UNIDO (EL)

Tyne & Wear
NEWCASTLE UPON TYNE

An open-label, multi-center controlled clinical trial of eculizumab in adolescent patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

ITALIA

LOMBARDIA
BRESCIA

Ensayo(s) clínico(s) multinacional(es)